Personalised medicine is a move away from a ‘one size fits all’ approach to the treatment and care of patients with a particular condition, to one which uses new approaches to better manage patients’ health and targets therapies to achieve the best outcomes in the management of a patient’s disease or predisposition to disease” (taken from NHS.uk). With the rapid improvements in accurateness of molecular diagnostics, progress in developing adequately tailored treatments is highly needed.
In over 10 years of academic research I have contributed to the understanding of molecular regulators of stem cell properties in brain cancer, a field of research with significant impact on our approach in personalized anti-cancer therapy. By using glioblastoma (GBM), the most common malignant brain tumor and one of the most lethal cancers, as a model disease my research was amongst the earliest discoveries that the stem cell signaling pathway Wingless/WNT contributes to the malignant behavior of the disease. Up till now, many facets of how and through what mechanisms, WNT promotes GBM malignancy have been identified. Those stem cell regulator- research campaigns also added to the establishment of cancer-subtype specific biomarkers suitable for disease stratification as a fundament that impacts our approaches to find novel therapeutic treatment options. Various efforts to develop pharmacological WNT blockers are active with promising clinical trials underway. Our follow-up studies identified several molecular targets of WNT in GBM with that can a) reduce resistance to standard of care treatment, b) eradicate cancer stem cells and c) help to detect tumor occurrence by minimal invasive approaches such as metabolic imaging.
The work has been supported by German Cancer Aid/ Deutsche Krebshilfe and is currently supported by Brigitte und Dr. Konstanze Wegener Foundation.
Starting from winter semester 2019/2020 as part of the (Science Track Elective Course Curriculum in the Model Program Degree of Medicine at the Heinrich-Heine University of Duesseldorf, http://www.medizin.hhu.de/studium-und-lehre/studiengaenge/medizin/wahlfach-datenbank.html, Dr. Kahlert is discussing current breakthrough discoveries on Personalized Medicine. Special emphasize on applicability of the finding of the discussed papers for clinical practice is drawn.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.
Other external services
We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Vimeo and Youtube video embeds: